Abstract

Personalized medicine—the customization of medical treatment to an individual's genetic profile—aims to both improve outcomes and control costs. But recent news, including scandals involving direct-to-consumer genetic tests and questions about targeted cancer therapies, has exposed many ethical hurdles. They are explored here by ethicists, a patient, a medical student, and a consumer advocate.

pdf

Share